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background: Delirium is a common manifestation of brain organ dysfunction characterized by inattention and abnormal mental status. It is 
independently predictive of worse clinical outcomes and higher mortality in many populations. Transcatheter aortic valve replacement (TAVR) is often 
chosen over a surgical approach (SAVR) in older patients and those with comorbidities including decreased left ventricular ejection fraction, factors 
that pose a high risk of developing delirium. The prevalence and clinical significance of delirium following TAVR is unknown.
Methods: Baseline demographic data and daily assessments for delirium using the Confusion Assessment Method-ICU (CAM-ICU) were 
prospectively recorded for patients undergoing either TAVR or SAVR between 7/2011 and 8/2012. Multivariable logistic regression assessed the 
relationship between procedure type as the independent variable and delirium on any of the first three post-operative days as the dependent 
variable, adjusting for age and baseline comorbidity. A secondary analysis assessed the relationship between post-operative delirium as the 
independent variable and 6-month survival, adjusting for procedure type and age.
results: Of 233 patients, 108 underwent TAVR and 125 SAVR. TAVR patients were older (median age 81 vs. 68, p<0.001) and had more baseline 
comorbidities (median Charlson 3 vs. 2, p<0.001). The prevalence of post-operative delirium was 19% in TAVR patients vs. 22% in SAVR patients. 
After adjusting for age and comorbidities, patients undergoing TAVR had lower odds of developing delirium compared to SAVR [Odds ratio, OR 
0.4 (0.18-0.92), p=0.03]. Mortality was higher at 6 months in the TAVR group vs. SAVR (14.3% vs. 2.5%, p=0.001). Delirium was independently 
associated with a 3-fold higher risk of death by 6 months [Hazard ratio, HR 3.3 (1.27-8.9) p=0.014], irrespective of procedure type and age.
conclusion: Despite older age and comorbidity burden at baseline, patients undergoing TAVR have a lower probability of developing delirium than 
SAVR patients. Delirium in both groups portended a 3-fold higher risk of death, supporting that monitoring for this form of organ dysfunction should 
be standard in all AVR patients.
